ScaleUp Bio has received a food manufacturing license from the Singapore Food Agency (SFA) for its commercial pilot production facility located in Tuas, Singapore.

The 2266-square-metre production facility will focus on submerged microbial and precision fermentation services at a scale of up to 10,000 litres, as well as downstream processing capacity.

This move signifies that ScaleUp Bio has successfully met the criteria of Singapore’s food production standards, which encompass requirements for ensuring adherence to specific infrastructure and facility standards for food safety production, emphasising training, collaboration and regulatory compliance to uphold hygiene and operational criteria.

ScaleUp Bio said this makes it one of the few CDMO’s in the world that is approved as a food manufacturing facility.

The new facility complements the company’s Fermentation Joint Lab, designed and operated in conjunction with the Agency for Science, Technology and Research’s Singapore Institute of Food and Biotechnology Innovation. The Fermentation Joint lab is housed in Nurasa’s Food Tech Innovation Centre and enables food innovators to bring an idea to life, offering start-ups up to 100 litres of fermentation capacity in a dedicated food grade, scientific research laboratory.

Francisco Codoñer, CEO of ScaleUp Bio, said: “We are deeply grateful to SFA for this milestone, and we are ready to go. If you are a global food tech start-up in need of pilot-scale manufacturing, we invite you to engage with us. ScaleUp Bio’s value proposition offers anyone with the next best concept in food to bring that idea to reality, and to pilot stage commercial production in Singapore, backed by a blue-chip corporate ecosystem of support. With this milestone, we are moving one step forward towards enabling the next food revolution.”

Guo Xiu Ling, CEO of Nurasa, added: “At Nurasa, we are committed to pioneering a new world of sustainably produced nutrition solutions for our planet. ScaleUp Bio’s milestone from SFA is a pivotal step forward in this journey.”

Gary McGuigan, president, Asia-Pacific at ADM, ScaleUp Bio’s other corporate parent, commented: “ScaleUp Bio stands as a significant joint venture with Temasek’s Nurasa, demonstrating our commitment to meeting Asia’s unique food needs. Congratulations to the team on receiving the SFA’s food manufacturing licence, and we look forward to continuing our support for ScaleUp Bio and aspiring food-tech companies as we collectively pave the way for a more sustainable food system.”

Codoñer concluded: “ScaleUp Bio’s two facilities represent a pioneering initiative for Singapore and globally. Need food-grade facilities? We’ve got you covered. From R&D to pilot scale, our fermentation expertise ensures excellence. Transitioning from bench to market? Our collaborative ecosystem, including parent and sister companies, research institutions, and industry partners, offers guidance. Seeking funding? We tap into our parent companies’ extensive corporate network, ADM and Nurasa. Reach out to us now, and let’s help you ScaleUp for success in Asia’s lucrative markets.”

#ScaleUpBio #Singapore